{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Acivicin",
  "nciThesaurus": {
    "casRegistry": "42228-92-2",
    "chebiId": "",
    "chemicalFormula": "C5H7ClN2O3",
    "definition": "A modified amino acid and structural analog of glutamine.  Acivicin inhibits glutamine amidotransferases in the purine and pyrimidine biosynthetic pathways, thereby inhibiting tumor growth in cell lines dependent on glutamine metabolism.",
    "fdaUniiCode": "O0X60K76I6",
    "identifier": "C986",
    "preferredName": "Acivicin",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C2158"
    ],
    "synonyms": [
      "(S-(R*,R*))-4,5-Dihydro-alpha-amino-3-chloro-5-isoxazoleacetic Acid",
      "ACIVICIN",
      "AT-125",
      "Acivicin",
      "U-42126"
    ]
  }
}